▶ GHK-CU · SUBTOPIC · MECHANISM
GHK-Cu Mechanism
For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.
MECHANISM OF ACTION
Naturally occurring tripeptide Gly-His-Lys bound to a Cu²⁺ ion. Peer-reviewed for collagen-synthesis induction, glycosaminoglycan production, and tissue-remodeling transcriptional signaling.
PHARMACOKINETIC HALF-LIFE
Reported half-life for GHK-Cu: Short (minutes) in plasma; longer in tissue depots. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.
PRIMARY SEQUENCE
GHK-Cu is a defined sequence: Gly-His-Lys + Cu²⁺. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.
MECHANISM CATEGORIES
GHK-Cu is tagged in 3 mechanism categories on GIGARESEARCH. Each category aggregates the broader pharmacology of related compounds.
Tissue repair encompasses the coordinated processes of inflammation resolution, cell migration, extracellular-matrix remodeling, and angiogenesis. Research peptides in this category include BPC-157 (pentadecapeptide cytoprotection), TB-500 (Thymosin Beta-4 actin sequestration), and GHK-Cu (copper-peptide collagen induction). The shared theme is permissive enhancement of healing processes already underway in injured tissue.
The dermal extracellular matrix comprises collagen (primarily type I and III), elastin, and glycosaminoglycans (hyaluronic acid, dermatan sulfate). Age-related skin changes reflect declining synthesis and increased degradation of these components. GHK-Cu is the most-studied research peptide for direct transcriptional induction of dermal-matrix synthesis.
The longevity category includes compounds acting on canonical aging-biology pathways: sirtuins (NAD+-dependent deacylases), mitochondrial function and biogenesis, cellular senescence, autophagy, and the AMPK/mTOR axis. NAD+ and its precursors are the most-studied longevity compounds; MOTS-c (mitochondrial-derived peptide) is an emerging category.
MECHANISTIC OUTCOMES IN LITERATURE
The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with GIGARESEARCH evidence grades. Grades reflect study quality and replication, not clinical recommendation.
Multiple peer-reviewed papers (Pickart 2008 PMID 18644225; Pickart 2012 PMID 22666519). Mechanism well-characterized in dermal fibroblasts.
Canapp 2003 dog ischemic wound model (PMID 14648531). Replicated across rodent and porcine models.
Conference-abstract level (Leyden 2002) and book-chapter compilations report improvement in fine lines, density, and clarity from 0.05–0.1% topical creams. Not full RCT publications.
Community-reported anecdotal. No completed Phase 3 hair-loss trials with GHK-Cu as primary intervention.
Pickart 2015 transcriptomic study reported modulation of multiple thousand genes in fibroblasts at the dose tested. Magnitude varies by cell type, dose, exposure window.
MECHANISM Q+A
▶ GHK-Cu for skin · does it work?
Topical evidence for skin improvement is strong at the mechanism level (collagen, elastin, GAG synthesis upregulation in fibroblasts) and moderate at the human cosmetic-trial level (Leyden 2002 conference abstract; Finkley 2005 book chapter). Most published topical work uses 0.01–0.1% formulations.
▶ GHK-Cu for hair loss · does it work?
Mechanism-level data show GHK-Cu enlarges hair follicles and prolongs the anagen phase in rodent models. Human hair-loss clinical evidence is anecdotal; no completed Phase 3 trials with GHK-Cu as the primary intervention.
CITED LITERATURE
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008. PMID 18644225. link
- Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev 2012. PMID 22666519. link
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci 2018. PMID 29986520. link
- Canapp SO Jr, et al.. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg 2003. PMID 14648531. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-19